Christine MacCracken is the Head of Patient Strategies & Solutions for the Janssen Pharmaceutical Companies of Johnson & Johnson. In this role, Christine leads strategic identification and implementation of patient-centered initiatives such as pre-approval access, and collaborating closely with internal and external stakeholders to elevate the voice of the patient. She is an active member of the J&J Bioethics Committee, Patient Engagement Leadership Team, and has served as a Strategic Advisory Board Member for Patient Focused Medicines Development.  Her guiding principle is "every patient is a person first".